Tag: <span>covaxin</span>

Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals

Dhanraj SharmaJuly 3, 2021

In what Hyderabad-based Bharat Biotech claims is the largest efficacy trial in India across 25 trial sites, the company claims its Covid-19 vaccine Covaxin is 65 per cent effective against...

COVID-19

Aarogya Setu rolls out new feature to update Vaccination Status

CS SURBHI SAXENAJune 1, 2021

As per the press release by PIB, Aarogya Setu has rolled out a feature to update Vaccination Status on the Aarogya Setu App. Here is the step wise explanation of...

COVID-19

Government Supports Augmentation of Manufacturing Capacity for COVAXIN production under Mission COVID Suraksha

CS SURBHI SAXENAMay 15, 2021

Under Atma Nirbhar Bharat 3.0 Mission COVID Suraksha was announced by the Government of India, to accelerate the development and production of Indigenous COVID Vaccines. This is being implemented by...

COVID-19

DCGI approves Phase 2 and 3 clinical trial of COVAXIN in the age group of 2 to 18 Years

CS SURBHI SAXENAMay 13, 2021

The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct...

COVID-19

Bharat Biotech to sell Covaxin at Rs 600 to States, Rs 1200 to private hospitals

CS SURBHI SAXENAApril 25, 2021

Bharat Biotech has announced the cost of COVAXIN for State governments and Private Hospitals. It will cost 600 rupees per dose for State Governments and 1200 rupees per dose for...

NATIONAL NEWS

PM Modi interacted with Chief Ministers of all states

CS SURBHI SAXENAJanuary 12, 2021January 12, 2021

Interacting with the Chief Ministers of all states, Mr Modi took stock of COVID-19 situation and discussed vaccination roll out programme. He said, two vaccines Covishield and Covaxin, which are made in India, have been granted approval for emergency use. He said, both the vaccines are cost-effective.

NATIONAL NEWS

DCGI clears Covid-19 vaccines Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin for restricted use in emergency

CS SURBHI SAXENAJanuary 4, 2021January 4, 2021

DCGI clears Covid-19 vaccines Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin for restricted use in emergency

NATIONAL NEWS

India’s indigenous coronavirus vaccine ‘Covaxin’ shows no serious adverse effects in people in its 1st phase clinical trials

CS SURBHI SAXENADecember 18, 2020December 18, 2020

India's indigenous coronavirus vaccine ‘Covaxin’ shows no serious adverse effects in people in its 1st phase clinical trials India's indigenous coronavirus vaccine, Covaxin, has shown to generate robust immune response...

Tag: covaxin

Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals

Aarogya Setu rolls out new feature to update Vaccination Status

Government Supports Augmentation of Manufacturing Capacity for COVAXIN production under Mission COVID Suraksha

DCGI approves Phase 2 and 3 clinical trial of COVAXIN in the age group of 2 to 18 Years

Bharat Biotech to sell Covaxin at Rs 600 to States, Rs 1200 to private hospitals

PM Modi interacted with Chief Ministers of all states

DCGI clears Covid-19 vaccines Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin for restricted use in emergency

India’s indigenous coronavirus vaccine ‘Covaxin’ shows no serious adverse effects in people in its 1st phase clinical trials

Read on App

Rajasthan: Sikar records lowest minimum temperature of 0.5°C

ISRO successfully launches country’s communication satellite CMS-01